Cargando…

Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets

BACKGROUND: Transmission of highly pathogenic avian H5N1 viruses from poultry to humans have raised fears of an impending influenza pandemic. Concerted efforts are underway to prepare effective vaccines and therapies including polyclonal or monoclonal antibodies against H5N1. Current efforts are ham...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khurana, Surender, Suguitan, Amorsolo L., Rivera, Yonaira, Simmons, Cameron P., Lanzavecchia, Antonio, Sallusto, Federica, Manischewitz, Jody, King, Lisa R., Subbarao, Kanta, Golding, Hana
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661249/ https://www.ncbi.nlm.nih.gov/pubmed/19381279 http://dx.doi.org/10.1371/journal.pmed.1000049

Ejemplares similares

Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza
por: Simmons, Cameron P, et al.
Publicado: (2007)

A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells
por: Lu, Hanxin, et al.
Publicado: (2011)

Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2015)

Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus
por: Khurana, Surender, et al.
Publicado: (2010)

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
por: Khurana, Surender, et al.
Publicado: (2018)

Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients
por: Tang, Juanjie, et al.
Publicado: (2021)

Human monoclonal antibodies by immortalization of memory B cells
por: Lanzavecchia, Antonio, et al.
Publicado: (2007)

Eurasian-Origin Gene Segments Contribute to the Transmissibility, Aerosol Release, and Morphology of the 2009 Pandemic H1N1 Influenza Virus
por: Lakdawala, Seema S., et al.
Publicado: (2011)

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins
por: Fuentes, Sandra, et al.
Publicado: (2016)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
por: Suguitan, Amorsolo L, et al.
Publicado: (2006)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection
por: Bellusci, Lorenza, et al.
Publicado: (2023)

Influenza H5 Hemagglutinin DNA Primes the Antibody Response Elicited by the Live Attenuated Influenza A/Vietnam/1203/2004 Vaccine in Ferrets
por: Suguitan, Amorsolo L., et al.
Publicado: (2011)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

Scientific barriers to developing vaccines against avian influenza viruses
por: Subbarao, Kanta, et al.
Publicado: (2007)

A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin
por: Yu, Fei, et al.
Publicado: (2017)

AID Activity in B Cells Strongly Correlates with Polyclonal Antibody Affinity Maturation in-vivo Following Pandemic 2009-H1N1 Vaccination in Humans
por: Khurana, Surender, et al.
Publicado: (2012)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins
por: Khurana, Surender, et al.
Publicado: (2020)

Immune Response to SARS-CoV-2 Vaccine and Following Breakthrough Omicron Infection in an Autoimmune Patient with Hashimoto’s Thyroiditis, Pernicious Anemia, and Chronic Atrophic Autoimmune Gastritis: A Case Report
por: Cluff, Emily, et al.
Publicado: (2022)

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
por: Traggiai, Elisabetta, et al.
Publicado: (2004)

Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera
por: Sanchez, Carlos J, et al.
Publicado: (2011)

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases
por: Guo, Jian-Ping, et al.
Publicado: (2004)

Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
por: Ding, Honglei, et al.
Publicado: (2021)

NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA
por: Francis, Thomas, et al.
Publicado: (1936)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan
por: Ma, Yingshuo, et al.
Publicado: (2021)

Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination
por: Lin, Yen Chih, et al.
Publicado: (2016)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains
por: Lee, Jeehyun, et al.
Publicado: (2018)

Engineering H5N1 avian influenza viruses to study human adaptation
por: Morens, David M., et al.
Publicado: (2012)

Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation
por: Sallusto, Federica, et al.
Publicado: (1999)

The instructive role of dendritic cells on T-cell responses
por: Sallusto, Federica, et al.
Publicado: (2002)

Human B cell memory
por: Lanzavecchia, Antonio, et al.
Publicado: (2009)

Influenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferrets
por: Suguitan, Amorsolo L, et al.
Publicado: (2014)

Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?
por: Gillim-Ross, Laura, et al.
Publicado: (2007)

BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS
por: Rothbard, Sidney
Publicado: (1945)

The Use of Convalescent Sera in Immune-Electron Microscopy to Detect Non-Suspected/New Viral Agents
por: Lavazza, Antonio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q72qjtvtiombi03qmtgp3qcdir